Margin collapsed, profit crashed; price hike bet misses guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Missed FY27 double-digit growth guidance (delivered 4.6% YoY). EBITDA target halved (17-18% → 7.62%). Subsidiary profitability delayed.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 revenues +4.6% YoY and PAT -73.2% sharply miss prior guidance for double-digit growth and 17-18% EBITDA margin (delivered 7.62%). Management credits manpower cost surge and delays price-hike benefit to Q4; near-term margin recovery hinges on unquantified cost cuts and unproven subsidiary turnarounds. High execution risk.
₹109.5 Cr
Revenue · +4.6% YoY₹2.1 Cr
Reported PAT · −73.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Double-digit FY27 revenue growth expected
OVERSTATEDQ2 YoY +4.6%, QoQ +3.6%; well below double-digit
FY27 standalone EBITDA 17-18% margin
MISSStandalone EBITDA margin 7.62%; down from 15.2% prior year
Acemoney to reach EBITDA breakeven in Q3
OVERSTATEDAcemoney only 'near' breakeven in Q2; turnaround lagging guidance
Subsidiaries to turn profitable in H2 FY27
OVERSTATEDStill in loss-arrest phase; RVL showing 35% growth but Acemoney not yet profitable
Direct client business at 20%, growing to 33% of revenues
METDirect clients 19.2% in Q2; slow progression from 15.7% YoY
Earnings quality
What changed since the last call
Revenue growth guidance cut implicitly
DowngradePrior: 'double-digit growth expected.' Delivered: +4.6% YoY. No explicit new guidance, but acknowledge slowdown.
EBITDA margin halved vs prior year
DowngradeFY27 guidance 17-18% margin; Q2 delivered 7.62% (down from 15.2% YoY). Manpower costs blamed; price hikes lagging.
Subsidiary profitability pushed back
DowngradeAcemoney 'near breakeven' (not yet profitable); RVL early stage. Guidance for H2 FY27 profitability now uncertain.
Price hike strategy deployed
New12-15% price revision across majority of clients; implementation phased from Nov (banks) to Dec (others). Benefit accrual Q4 onwards.
The Q&A
Analysts (Keshav Garg, Dilip) pressed hard on margin math and profitability path. Management held up, acknowledging cost pressures and citing price hikes + tech cost cuts, but hedged on magnitude/timing. No formal concession of guidance miss, but defensive tone evident.
Margin collapse vs industry — Keshav Garg, Counter Cyclical PMS
AnsweredPricing is uniform across industry; manpower (drivers, gunmen, cash execs = 70% of cost) has spiked due to wage increases. We obtained 12-15% price hikes industry-wide; full benefit from Q4.
Shareholder wealth destruction — Rohan, ACMS
DodgedProfitability has been a concern, but worst is behind us. Price revisions, cost cuts, subsidiary turnarounds, improved RVL/Acemoney will restore IPO-level profitability gradually and rapidly.
Touch point growth slowdown — Krushi Parekh, BugleRock
AnsweredBank partnerships not growing as expected. Pivoting to direct clients (~20% of revenue now, targeting 33%). Hiring sector-specific executives to build direct client base in organized retail, NBFCs, hospitals.
Price hike realisation & wage pressure — Amit, Individual Investor
PartialMost hikes from banks only; retail slower. Gunman shortage acute in few states. No clear visibility on wage easing, but we've passed increases to clients. Second round of hikes unlikely unless macro deteriorates.
Profitability math post-hike — Dilip, Individual Investor
PartialAcemoney near breakeven. RVL 35% growth Q1-Q2. Both will contribute positively to PAT soon. Price increase + cost reduction (tech + hiring SMEs) will close gap. We're confident of restoration.
Election-period cash flow impact — Balakrishna, Individual Investor
AnsweredElections happened before with no material impact on cash movement. Clearances in place. No impact expected on volume handling.
Guidance
FY27 mid-teens growth expected (implicit from 'double-digit' prior)
LowQ2 delivered only +4.6% YoY. Full-year trajectory weak unless Q3-Q4 acceleration. Direct client push underway but not yet material.
FY27 standalone EBITDA 17-18% (contingent on price revision)
LowQ2 at 7.62%; price hikes lagging to Q4. Even with full benefit, path to 17-18% unclear without deeper cost cuts or higher price realization.
Profitability improvement from Q4 onwards via price hikes + cost reduction
MediumPrice hikes confirmed (12-15%, mostly by Dec). Tech-driven cost cuts unquantified. Subsidiary contribution timing uncertain.
No major capex expected; vans on lease
HighSubsidiary capex minimal (Acemoney sound boxes self-liquidating purchases). Capital-light model maintained.
Risks the call surfaced
Manpower cost inflation
HighMinimum wage increases (North/Central states particularly), guard shortage in southern states, driver and cash executive costs spiking. 70% of cost base affected.
Subsidiary turnaround execution
HighAcemoney 'near breakeven' (not yet profitable). RVL early-stage growth. Both still dragging consolidated PAT. Profitability promised for H2 but timeline uncertain.
Price hike realization risk
Medium12-15% price hikes secured but phased implementation (Nov for banks, Dec for retail). Benefit accrual delayed to Q4. Analyst Dilip challenged whether margin swing from -5% (current) to +20% (IPO level) is realistic even with hikes.
Bank partnership growth stalled
MediumBank-driven growth (80% of revenue) slowing; retail partnerships not expanding as expected. Direct client shift strategy unproven at scale (only 20% of revenue, slow growth from 15.7% YoY).
Profitability restoration credibility
HighMissed FY27 double-digit growth (delivered 4.6% YoY) and EBITDA 17-18% target (delivered 7.62%). Subsidiary profitability delayed. Management reaffirming confidence without quantified path to recovery.
Management
Score 6/10. Transparent on challenges (acknowledges profitability concern, cost spikes, guidance misses), but hedges on specifics. Reaffirms confidence without quantifying margin path or subsidiary turnaround timeline. Obtained price hikes (12-15% confirmed), lagging implementation (Q4). Missed Q2 guidance on revenue (+4.6% vs double-digit) and EBITDA (7.62% vs 17-18%). Subsidiary turnarounds delayed.
1 · Dec 2026
Price revision impact kicks in; majority of 12-15% hikes effective
2 · Q3 FY27
Acemoney expected to contribute positively to PAT; management targets profitability
3 · H2 FY27
Radiant Valuable Logistics and Acemoney both to turn profitable (management claim)
High execution risk.
Informational and educational content only. Not investment advice.